In a message dated 10/13/2004 1:11:49 PM Eastern Daylight Time,
[log in to unmask] writes:

She said  that
the she was not at liberty to divulge the full reasoning behind  the
statement.  If people are interested in more information, she said  they
would have to ask the drug manufacturers.  The FDA cannot reveal  proprietary
data taken into account in making this  decision.



Judy, Dr. Wood's comment does not convince me that there is solid evidence
of serious risk from Domperidone.  I will tend to believe Dr. Hale and the
European community on this one.

Our FDA is in bed with the pharmasuitical industry and they are prone to
rule in their favor.  In a perfect world, the FDA would be totally unbiased  but
it will never be a perfect world.  :-(
I think what we in the lactation community can do is continue to press for
evidence based answers and press the agencies such as the FDA for solid
research  and not "just trust me on this one" answers.

Ann Perry, RN IBCLC
Boston, MA

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html